DENVER, Jan. 21, 2011 (GLOBE NEWSWIRE) -- MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States, is pleased to announce that it has teamed up with bodybuilding.com to run a series of commercials that will air on ESPN and Spike TV Networks.
MusclePharm will be debuting its "Confidence" Commercial for the first time featuring UFC Star Rashad Evans on Spike TV during this weekend's UFC Event at 9pm EST. There is estimated to be 1.3 million viewers for the UFC Fight "For the Troops Event".
"We are excited about this commercial campaign as it will allow us to continue to showcase our brand on major networks and continue to grow our company aggressively to new audiences," commented Brad Pyatt, MusclePharm's CEO. "MusclePharm's brand awareness and market penetration has increased substantially in a short period of time and we are excited to see how this campaign will increase our awareness and ultimately our 2011 sales."
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit www.musclepharm.com.
MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.
CONTACT: Investor Contact ICR John Mills, Senior Managing Director 310. 954. 1105